Literature DB >> 20639383

The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration.

Jonathan D Rohrer, Tammaryn Lashley, Janice Holton, Tamas Revesz, Hazel Urwin, Adrian M Isaacs, Nick C Fox, Martin N Rossor, Jason Warren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20639383     DOI： 10.1136/jnnp.2010.214437

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  15 in total

1.  Clinical characterization of bvFTD due to FUS neuropathology.

Authors:  Suzee E Lee; William W Seeley; Pardis Poorzand; Rosa Rademakers; Anna Karydas; Christine M Stanley; Bruce L Miller; Katherine P Rankin
Journal:  Neurocase       Date:  2011-11-07       Impact factor: 0.881

2.  Pathological heterogeneity in amyotrophic lateral sclerosis with FUS mutations: two distinct patterns correlating with disease severity and mutation.

Authors:  Ian R A Mackenzie; Olaf Ansorge; Michael Strong; Juan Bilbao; Lorne Zinman; Lee-Cyn Ang; Matt Baker; Heather Stewart; Andrew Eisen; Rosa Rademakers; Manuela Neumann
Journal:  Acta Neuropathol       Date:  2011-05-21       Impact factor: 17.088

Review 3.  FTD spectrum: Neuroimaging across the FTD spectrum.

Authors:  Jennifer L Whitwell
Journal:  Prog Mol Biol Transl Sci       Date:  2019-06-18       Impact factor: 3.622

Review 4.  Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.

Authors:  Ian R A Mackenzie; Manuela Neumann; Nigel J Cairns; David G Munoz; Adrian M Isaacs
Journal:  J Mol Neurosci       Date:  2011-05-21       Impact factor: 3.444

Review 5.  Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology.

Authors:  Jennifer L Whitwell; Keith A Josephs
Journal:  Nat Rev Neurol       Date:  2012-01-31       Impact factor: 42.937

6.  FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.

Authors:  Manuela Neumann; Eva Bentmann; Dorothee Dormann; Ali Jawaid; Mariely DeJesus-Hernandez; Olaf Ansorge; Sigrun Roeber; Hans A Kretzschmar; David G Munoz; Hirofumi Kusaka; Osamu Yokota; Lee-Cyn Ang; Juan Bilbao; Rosa Rademakers; Christian Haass; Ian R A Mackenzie
Journal:  Brain       Date:  2011-08-19       Impact factor: 13.501

Review 7.  Behavioural variant frontotemporal dementia--defining genetic and pathological subtypes.

Authors:  Jonathan D Rohrer
Journal:  J Mol Neurosci       Date:  2011-05-11       Impact factor: 3.444

8.  Shape analysis of the corpus callosum in Alzheimer's disease and frontotemporal lobar degeneration subtypes.

Authors:  Mark Walterfang; Eileen Luders; Jeffrey C L Looi; Priya Rajagopalan; Dennis Velakoulis; Paul M Thompson; Olof Lindberg; Per Ostberg; Love E Nordin; Leif Svensson; Lars-Olof Wahlund
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies.

Authors:  Tammaryn Lashley; Jonathan D Rohrer; Rina Bandopadhyay; Charles Fry; Zeshan Ahmed; Adrian M Isaacs; Jack H Brelstaff; Barbara Borroni; Jason D Warren; Claire Troakes; Andrew King; Safa Al-Saraj; Jia Newcombe; Niall Quinn; Karen Ostergaard; Henrik Daa Schrøder; Marie Bojsen-Møller; Hans Braendgaard; Nick C Fox; Martin N Rossor; Andrew J Lees; Janice L Holton; Tamas Revesz
Journal:  Brain       Date:  2011-07-12       Impact factor: 13.501

10.  Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.

Authors:  Manuela Neumann; Edward B Lee; Ian R Mackenzie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.